Olon

Rodano (Milan), Italy
ADC (end-to-end) HPAPI API (small molecule) Biologics (mammalian & microbial) mAb Bioconjugation Fill & Finish
Program data pending ClinicalTrials.gov matching
60.0
Signal Score
○ FDA Inspections ○ Clinical Trials ○ SEC Filings ✓ Press (5) ○ EMA GMP ○ MHRA GMP

Quick Facts: Olon

Signal Score
60.0/100
Quality Compliance
Assessment pending
Headquarters
Rodano (Milan), Italy
Modalities
ADC (end-to-end), HPAPI, API (small molecule), Biologics (mammalian & microbial), mAb, Bioconjugation, Fill & Finish
Active Programs
No ClinicalTrials.gov matches confirmed
Data Sources
FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
Scored By
CDMO Signal — independent CDMO intelligence platform

About Olon

Auto-created by AI matchmaker. Data verification pending.

Signal Score & Pillar Breakdown

Quality Compliance —
No FDA inspection records found. This CDMO may operate under a different legal name or may not have US FDA-inspected facilities.
FDA InspectionsNo US records on file
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Operations —
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs — no verified data
Sponsors— no verified data
ModalitiesADC (end-to-end), HPAPI, API (small molecule), Biologics (mammalian & microbial), mAb, Bioconjugation, Fill & Finish
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Financial Stability 60.0
Private company
Financial assessment: 60.0/100
Source: SEC EDGAR, press monitoring
Profile-based financial assessment
SEC FilingsPrivate company
Private company
Financial assessment: 60.0/100
Capacity 60.0
Broad modality coverage (7 modalities)
Source: SEC EDGAR, press monitoring, company profiles
Profile-based capacity assessment
Recent Press5 articles
Broad modality coverage (7 modalities)

Recent News 5 articles

news Wed, 24 Ju
Olon S.p.A. Expands Microbial GMP Capabilities at Its Manufacturing Site in Capua - PR Newswire
Source →
news Wed, 05 Se
Italian CDMO buys India API plant that supplies Novartis - Fierce Pharma
Source →
news Thu, 18 Ap
Olon Buys Indian API Plant - CHEManager
Source →
news Mon, 28 Ja
Olon SpA Acquires Italian CDMO - Contract Pharma
Source →
news Fri, 25 Ja
Olon acquires fellow Italian CDMO - The Pharma Letter
Source →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
ADC (end-to-end) CDMOs → HPAPI CDMOs → API (small molecule) CDMOs → Biologics (mammalian & microbial) CDMOs → mAb CDMOs → Bioconjugation CDMOs → Fill & Finish CDMOs →

Similar CDMOs

Abzena
San Diego, CA
ADC, AOC, RDC, Biologics, mAb, HPAPI, Bioconjugation
Roche / Genentech (Internal Manufacturing & CustomBiotech)
Basel, Switzerland
Biologics, mAb, Cell Therapy, Gene Therapy (AAV), Oligonucleotide, mRNA, Small Molecule
Altruist Biologics
Suzhou, China
Biologics, mAb, Bispecific/Multispecific Antibodies, Fusion Proteins, Recombinant Proteins, ADC, Cell Therapy, Gene Therapy